You are here

remdesivir

FDA grants approval for Veklury use in Covid-19 patients with severe renal impairment

Pharmaceutical Business Review

Mon, 07/17/23 - 10:01 am

Gilead Sciences

Study identifies Covid-19 patients with mutations indicating remdesivir resistance

Endpoints

Wed, 09/28/22 - 10:27 pm

Gilead Sciences

Gilead collects 5th priority review voucher as public advocacy group urged the company to relinquish it

Endpoints

Tue, 05/3/22 - 10:49 am

Gilead Sciences

priority review

Gilead’s Covid-19 treatment Veklury props up first quarter gains amid $2.7B Trodelvy writedown

Endpoints

Fri, 04/29/22 - 10:31 am

Gilead Sciences

FDA approves first COVID treatment for children under 12

Axios

Mon, 04/25/22 - 11:02 pm

Gilead Sciences

Gilead touts analysis showing COVID antiviral Veklury performs best when given early in illness

Fierce Pharma

Mon, 04/25/22 - 10:21 am

Gilead Sciences

Despite strong quarter, some wonder how long Gilead can rely on coronavirus drug

BioPharma Dive

Fri, 10/29/21 - 11:17 am

Gilead Sciences

Remdesivir reduces Covid hospitalizations when given early, study shows

Stat

Wed, 09/22/21 - 11:20 am

Gilead Sciences

Oral Remdesivir Could Lower COVID Hospitalizations, Preclinical Study Says

BioSpace

Mon, 08/23/21 - 11:29 pm

Gilead Sciences

Real-world remdesivir data add to body of evidence for Gilead Sciences Covid-19 drug

MedCity News

Tue, 06/22/21 - 11:09 am

Gilead Sciences

real world data

real world evidence

Gilead stops Veklury study, citing enrollment challenges, changing treatment

BioPharma Dive

Tue, 04/13/21 - 10:05 pm

Gilead Sciences

clinical trials

India axes exports of Gilead Sciences' remdesivir, plots boost to local production as COVID cases mount: reports

Fierce Pharma

Mon, 04/12/21 - 10:59 pm

drug manufacturing

Gilead Sciences

Pharma Gilead has sole rights to COVID-19 blockbuster Veklury, GAO concludes

Fierce Pharma

Thu, 04/1/21 - 11:42 pm

Gilead Sciences

Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers

KHN

Wed, 01/27/21 - 08:07 pm

Gilead Sciences

Cancer drug derived from sea squirts outperforms remdesivir in COVID-19 preclinical models

Fierce Biotech

Wed, 01/27/21 - 11:22 am

Gilead says Veklury should work against COVID-19 variants

Pharmaforum

Fri, 01/22/21 - 10:42 am

Gilead Sciences

B.1.1.7 variant

Gilead Updates 2020 Guidance with Post-Holiday COVID-19 Spike

BioSpace

Wed, 01/13/21 - 12:07 am

Gilead Sciences

Could a lymphoma drug work better against COVID-19 than Gilead's remdesivir?

Fierce Biotech

Sun, 01/3/21 - 04:29 pm

Gilead Sciences

Acrotech Biopharma

Fierce Pharma's top 2020 marketing stories pack pandemic punch to digital, reputation and drug launches

Fierce Pharma

Wed, 12/23/20 - 10:51 am

pharma marketing

Gilead Sciences

Where Will Gilead Sciences Be in 1 Year?

Motley Fool

Wed, 12/23/20 - 10:42 am

Gilead Sciences

Pages